Brief: Hemogenyx Pharmaceuticals Files Annual IND Report With FDA For HG-CT-1 Car-T Therapy For AML
03/04/2025 07:22
April 3 (Reuters) - Hemogenyx Pharmaceuticals PLC HEMO.L: HEMOGENYX PHARMACEUTICALS PLC: FILES ANNUAL IND REPORT WITH FDA FOR HG-CT-1 CAR-T THERAPY FOR AML Source text: ID:nRSC4304Da Further company coverage: HEMO.L ((Reuters.Briefs@thomsonreuters.com;))